European Guidelines on cardiovascular disease prevention in clinical practice (version 2012)

Cited by (1,089)

Items 501–600 of 1,089

1. Role of cardiovascular magnetic resonance in the guidelines of the European Society of Cardiology
   Florian von Knobelsdorff‐Brenkenhoff, Jeanette Schulz‐Menger · 2016 · Journal of Cardiovascular Magnetic Resonance
2. Can we improve the nutritional quality of meat?
   Nigel David Scollan, Eleri M. Price, Sarah A. Morgan, Sharon Huws, Kevin J. Shingfield · 2017 · Proceedings of The Nutrition Society
3. Equalization of four cardiovascular risk algorithms after systematic recalibration: individual-participant meta-analysis of 86 prospective studies
   Lisa A M Pennells, Stephen K. Kaptoge, Angela Wood, Mike Sweeting, Xiaohui Zhao, Ian R. White, Stephen Burgess, Peter Willeit, Thomas R Bolton, Karel G.M. Moons et al. · 2018 · European Heart Journal
4. Effect of empagliflozin on ectopic fat stores and myocardial energetics in type 2 diabetes: the EMPACEF study
   Bénédicte Gaborit, Patricia Ancel, Amany Abdullah, F. Maurice, Inès Abdesselam, Andreea Calen, Astrid Soghomonian, Marie Houssays, Isabelle Varlet, Mark J. Eisinger et al. · 2021 · Cardiovascular Diabetology
5. Work stress and risk of death in men and women with and without cardiometabolic disease: a multicohort study
   M. Kivimäki, J. Pentti, J. Ferrie, G. Batty, S. Nyberg, M. Jokela, M. Virtanen, L. Alfredsson, N. Dragano, E. Fransson et al. · 2018 · The Lancet Diabetes and Endocrinology
6. Nonfasting lipids, lipoproteins, and apolipoproteins in individuals with and without diabetes: 58 434 individuals from the Copenhagen General Population Study
   Langsted, Anne, Nordestgaard, Børge G · 2011 · Clinical Chemistry
7. Integrated guidance on the care of familial hypercholesterolemia from the International FH Foundation
   Gerald Francis Watts, Samuel S. Gidding, Anthony S. Wierzbicki, Peter Paul Toth, Rodrigo Alonso K, William Virgil Brown, Éric Bruckert, Joep C. Defesche, Khoo Kah Lin, Michael Livingston et al. · 2014 · Journal of clinical lipidology
8. Diretriz Brasileira de Reabilitação Cardiovascular – 2020
   Tales de Carvalho, Maurício Milani, Almir Sergio Ferraz, Anderson Donelli da Silveira, Artur Haddad Herdy, Carlos Alberto Cordeiro Hossri, Christina Grüne de Souza e Silva, Cláudio Gil Soares de Araújo, Enéas Antônio Rocco, José Antônio Caldas Teixeira et al. · 2020 · Arquivos Brasileiros de Cardiologia
9. 2016 European Guidelines on cardiovascular disease prevention in clinical practice: The Sixth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of 10 societies and by invited experts)
   F. Piepoli, Massimo · 2017 · International Journal of Behavioral Medicine
10. European Society of Cardiology/European Atherosclerosis Society Task Force consensus statement on proprotein convertase subtilisin/kexin type 9 inhibitors: practical guidance for use in patients at very high cardiovascular risk
    Ulf Landmesser, M. John Chapman, Michel Farnier, Bariş Gencer, Stephan Gielen, G. Kees Hovingh, Thomas Felix Lüscher, David Sinning, Lale S Tokgözoğlu, Olov Wiklund et al. · 2016 · European Heart Journal
11. Smartphone and social media-based cardiac rehabilitation and secondary prevention in China (SMART-CR/SP): a parallel-group, single-blind, randomised controlled trial
    Tashi Dorje, Gang Zhao, Khandro Tso, Jing Wang, Yaolin Chen, Lhamo Tsokey, B-K Tan, Anna Scheer, Angela Jacques, Zhixing Li et al. · 2019 · The Lancet Digital Health
12. Aspirin for the Prevention of Cancer Incidence and Mortality: Systematic Evidence Reviews for the U.S. Preventive Services Task Force
    Jessica Chubak, Evelyn P. Whitlock, Selvi B Williams, Aruna Kamineni, Brittany U Burda, Diana S.M. Buist, Melissa L. Anderson · 2016 · Annals of Internal Medicine
13. Fibrin clot properties independently predict adverse clinical outcome following acute coronary syndrome: a PLATO substudy
    Wael Sumaya, Lars C. Wallentin, Stefan Karl James, Agneta G Siegbahn, Katja Gabrysch, Maria Bertilsson, Anders Himmelmänn, Ramzi Ajjan, Robert F. Storey · 2018 · European Heart Journal
14. Improving prevention strategies for cardiometabolic disease
    Naveed A. Sattar, Jason M. R. Gill, William Alazawi · 2020 · Nature Medicine
15. Progression of Early Subclinical Atherosclerosis (PESA) Study
    Borja Ibáñez, Antonio Fernández‐Ortíz, Leticia Fernández‐Friera, Inés García‐Lunar, Vicente Andrés, Valentı́n Fuster · 2021 · Journal of the American College of Cardiology
16. Effects of total fat intake on body weight
    Lee Hooper, Asmaa S Abdelhamid, Diane K Bunn, Tracey J. Brown, Carolyn Summerbell, Clark Murray Skeaff · 2015 · Cochrane Database of Systematic Reviews
17. Interactions between erectile dysfunction, cardiovascular disease and cardiovascular drugs
    Dimitrios G. Terentes-Printzios, N. Ioakeimidis, Konstantinos Rokkas, Charalambos V. Vlachopoulos · 2021 · Nature Reviews Cardiology
18. Platelet Activation Is Associated With Myocardial Infarction in Patients With Pneumonia
    Roberto Cangemi, Marco Casciaro, Elisabetta Maria Cristina Rossi, Camilla Calvieri, Tommaso Bucci, Cinzia Myriam Calabrese, Gloria Taliani, Marco Falcone, Paolo Palange, Giuliano Bertazzoni et al. · 2014 · Journal of the American College of Cardiology
19. Seipin: from human disease to molecular mechanism
    Bethany R. Cartwright, Joel M. Goodman · 2012 · Journal of Lipid Research
20. Rosuvastatin: A Review of the Pharmacology and Clinical Effectiveness in Cardiovascular Disease
    Ahai Luvai, Wycliffe Mbagaya, Alistair S. Hall, Julian H. Barth · 2012 · Clinical Medicine Insights Cardiology
21. Guideline recommendations and the positioning of newer drugs in type 2 diabetes care
    Nikolaus Marx, Melanie Jane Davies, Peter J. Grant, Chantal Mathieu, John R. Petrie, Francesco Cosentino, John B. Buse · 2020 · The Lancet Diabetes & Endocrinology
22. CAC Score Improves Coronary and CV Risk Assessment Above Statin Indication by ESC and AHA/ACC Primary Prevention Guidelines
    Amir Abbas Mahabadi, Stefan Möhlenkamp, Nils Lehmann, Hagen Kälsch, Iryna Dykun, Noreen Pundt, Susanne Moebus, Karl‐Heinz Jöckel, Raimund M. Erbel · 2016 · JACC. Cardiovascular imaging
23. Role of aspirin in primary prevention of cardiovascular disease
    Carlo Patrono, Colin Baigent · 2019 · Nature Reviews Cardiology
24. Interventions for improving modifiable risk factor control in the secondary prevention of stroke
    Bernadeta M Bridgwood, Kate E Lager, Amit K. Mistri, Kamlesh Khunti, Andrew Wilson, Priya Modi · 2018 · Cochrane Database of Systematic Reviews
25. Intake of Fatty Acids in General Populations Worldwide Does Not Meet Dietary Recommendations to Prevent Coronary Heart Disease: A Systematic Review of Data from 40 Countries
    Rajwinder K. Harika, Ans Eilander, Marjan Alssema, Saskia J. M. Osendarp, Peter L. Zock · 2013 · Annals of Nutrition and Metabolism
26. Subclinical thyroid dysfunction and cardiovascular diseases: 2016 update
    Carmen Floriani, Bariş Gencer, Tinh‐Hai Collet, Nicolas Rodondi · 2017 · European Heart Journal
27. Risk Factor Management in Atrial Fibrillation
    Axel Brandes, Marcelle D. Smit, Bao Oanh Nguyen, Michiel Rienstra, Isabelle C. Van Gelder · 2018 · Arrhythmia & Electrophysiology Review
28. Chinese Guidelines for the Prevention and Treatment of Hypertension (2024 revision)
    Ji‐Guang Wang · 2025 · 老年心脏病学杂志：英文版
29. Efficacy and safety of alirocumab, a monoclonal antibody to PCSK9, in statin-intolerant patients: design and rationale of ODYSSEY ALTERNATIVE, a randomized phase 3 trial
    Moriarty, Patrick M., Jacobson, Terry A., Bruckert, Eric, Thompson, Paul D., Guyton, John R., Baccara-Dinet, Marie T., Gipe, Daniel · 2014 · Journal of Clinical Lipidology
30. Aspirin for Primary Cardiovascular Risk Prevention and Beyond in Diabetes Mellitus
    Davide Capodanno, Dominick Joseph Angiolillo · 2016 · Circulation
31. ESC 2019 guidelines for the diagnosis and management of chronic coronary syndromes
    Antti Saraste, Juhani M. Knuuti · 2020 · Herz
32. Managing the residual cardiovascular disease risk associated with HDL-cholesterol and triglycerides in statin-treated patients: A clinical update
    Reiner, Ž. · 2013 · Nutrition, Metabolism and Cardiovascular Diseases
33. A simple nonexercise model of cardiorespiratory fitness predicts long-term mortality
    NES, BJARNE MARTENS, VATTEN, LARS J., NAUMAN, JAVAID, JANSZKY, IMRE, WISLØFF, ULRIK · 2014 · Medicine & Science in Sports & Exercise
34. Why are we failing to implement effective therapies in cardiovascular disease?
    Robby Nieuwlaat, Jon-David Schwalm, Rasha Khatib, Salim Yusuf · 2013 · European Heart Journal
35. The safety of therapeutic monoclonal antibodies: Implications for cardiovascular disease and targeting the PCSK9 pathway
    Alberico Luigi Catapano, Nicholas J. Papadopoulos · 2013 · Atherosclerosis
36. International consensus on the prevention of venous and arterial thrombotic events in patients with inflammatory bowel disease
    Pablo Andres Olivera, Stéphane Zuily, Paulo Gustavo Kotze, Véronique Regnault, Sameer Al Awadhi, Peter J. Bossuyt, Richard Blair Gearry, Subrata K. Ghosh, Taku Kobayashi, Patrick J. Lacolley et al. · 2021 · Nature Reviews Gastroenterology & Hepatology
37. Omega-3 Index and Cardiovascular Health
    Clemens von Schacky · 2014 · Nutrients
38. Dyslipidemia, Kidney Disease, and Cardiovascular Disease in Diabetic Patients
    Szu-chi Chen, Chin‐Hsiao Tseng · 2013 · The Review of Diabetic Studies
39. Effect of early-onset preeclampsia on cardiovascular risk in the fifth decade of life
    Anouk Bokslag, Pim W. Teunissen, Constantijn Franssen, Floortje van Kesteren, Otto Kamp, Wessel Ganzevoort, Walter J. Paulus, Christianne J.M. de Groot · 2017 · American Journal of Obstetrics and Gynecology
40. Rheumatoid arthritis-specific cardiovascular risk scores are not superior to general risk scores: a validation analysis of patients from seven countries
    Cynthia S. Crowson, Sherine E. Gabriel, Anne Grete Semb, Piet L. C. M. van Riel, George Athanasios Karpouzas, Patrick Hector Dessein, Carol Ann Hitchon, Virginia Pascual‐Ramos, George D. Kitas, Karen Douglas et al. · 2017 · Lara D. Veeken
41. Resting, night-time, and 24 h heart rate as markers of cardiovascular risk in middle-aged and elderly men and women with no apparent heart disease
    C. D. Johansen, Rasmus Huan Olsen, Laurids R Pedersen, Preman Kumarathurai, Mette Rauhe Mouridsen, Zeynep Binici, Theodoros Intzilakis, Lars Køber, Ahmad Sajadieh · 2013 · European Heart Journal
42. Primary prevention of ischaemic heart disease: populations, individuals, and health professionals
    Rajeev Gupta, David A. Wood · 2019 · The Lancet
43. Effects of a Vegetarian Diet on Cardiometabolic Risk Factors, Gut Microbiota, and Plasma Metabolome in Subjects With Ischemic Heart Disease: A Randomized, Crossover Study
    Demir Djekic, Lin Shan Shi, Harald Brolin, Frida Carlsson, Charlotte Särnqvist, Otto I. Savolainen, Yang Cao, Fredrik Bäckhed, Valentina Tremaroli, Rikard Landberg et al. · 2020 · Journal of the American Heart Association
44. Cardiovascular disease and COVID-19: a consensus paper from the ESC Working Group on Coronary Pathophysiology & Microcirculation, ESC Working Group on Thrombosis and the Association for Acute CardioVascular Care (ACVC), in collaboration with the European Heart Rhythm Association (EHRA)
    Edina Cenko, Lina Badimón, Raffaele Bugiardini, Marc J. Claeys, Giuseppe De Luca, Cor de Wit, Geneviève Dérumeaux, Maria Dorobanţu, Dirk Jan Duncker, Etto C. Eringa et al. · 2021 · Cardiovascular Research
45. Cardiac computed tomography and myocardial perfusion scintigraphy for risk stratification in asymptomatic individuals without known cardiovascular disease: a position statement of the Working Group on Nuclear Cardiology and Cardiac CT of the European Society of Cardiology
    Perrone-Filardi, Pasquale, Achenbach, Stephan, Möhlenkamp, Stefan, Reiner, Zeljko, Sambuceti, Gianmario, Schuijf, Joanne D., Van der Wall, Ernst, Kaufmann, Philip A., Knuuti, Juhani, Schroeder, Stephen et al. · 2011 · European Heart Journal
46. Magnitud y manejo de la hipercolesterolemia en la población adulta de España, 2008-2010: el estudio ENRICA
    Pilar Guallar‐Castillón, Miriam Gil-Montero, Luz María León-Muñoz, Auxiliadora Graciani, Ana Bayán-Bravo, José M. Taboada, José R. Banegas, Fernando Rodríguez‐Artalejo · 2012 · Revista Española de Cardiología
47. Use and effects of cardiac rehabilitation in patients with coronary heart disease: results from the EUROASPIRE III survey
    Kornelia Kotseva, David Wood, Guy De Backer, Dirk De Bacquer · 2012 · European Journal of Preventive Cardiology
48. Does pregnancy complication history improve cardiovascular disease risk prediction? Findings from the HUNT study in Norway
    Amanda Rose Markovitz, Jennifer J. Stuart, Julie Horn, Paige L. Williams, Eric B. Rimm, Stacey A. Missmer, Lauren J. Tanz, Eirin B. Haug, Abigail Fraser, Simon Timpka et al. · 2018 · European Heart Journal
49. Cardiovascular Risk in Type 1 Diabetes Mellitus
    Jonathan D. Schofield, Jan Hoong Ho, Handrean Soran · 2019 · Diabetes Therapy
50. Statin Treatment-Induced Development of Type 2 Diabetes: From Clinical Evidence to Mechanistic Insights
    Unai Galicia-García, Shifa Jebari‐Benslaiman, A. Larrea, Kepa B. Uribe, Haziq F. Siddiqi, Helena Ostolaza, Asier Benito‐Vicente, César Martı́n · 2020 · International Journal of Molecular Sciences
51. Poly-ADP-ribosylation in health and disease
    Marie-Ève Bonicalzi, Jean-François Haince, Arnaud Droit, Guy G. Poirier · 2005 · Cellular and Molecular Life Sciences
52. Effect of a high-fat Mediterranean diet on bodyweight and waist circumference: a prespecified secondary outcomes analysis of the PREDIMED randomised controlled trial
    Estruch, Ramon, Martínez-González, Miguel Angel, Corella, Dolores, Salas-Salvadó, Jordi, Fitó, Montserrat, Chiva-Blanch, Gemma, Fiol, Miquel, Gómez-Gracia, Enrique, Arós, Fernando, Lapetra, José et al. · 2019 · The Lancet Diabetes & Endocrinology · Retracted
53. Relations of change in plasma levels of LDL-C, non-HDL-C and apoB with risk reduction from statin therapy: a meta-analysis of randomized trials
    Thanassoulis, George, Williams, Ken, Ye, Keying, Brook, Robert, Couture, Patrick, Lawler, Patrick R., de Graaf, Jacqueline, Furberg, Curt D., Sniderman, Allan · 2014 · Journal of the American Heart Association
54. Trends in absolute and relative educational inequalities in four modifiable ischaemic heart disease risk factors: repeated cross-sectional surveys from the Nord-Trøndelag Health Study (HUNT) 1984–2008
    Linda Ernstsen, Bjørn Heine Strand, Sara Marie Nilsen, Geir Arild Espnes, Steinar Krokstad · 2012 · BMC Public Health
55. Real-world use and modeled impact of glucose-lowering therapies evaluated in recent cardiovascular outcomes trials: An NCDR® Research to Practice project
    Arnold, Suzanne V, Inzucchi, Silvio E, Tang, Fengming, McGuire, Darren K, Mehta, Sanjeev N, Maddox, Thomas M, Goyal, Abhinav, Sperling, Laurence S, Einhorn, Daniel, Wong, Nathan D et al. · 2017 · European Journal of Preventive Cardiology
56. Lifetime Risks for Cardiovascular Disease Mortality by Cardiorespiratory Fitness Levels Measured at Ages 45, 55, and 65 Years in Men
    Jarett D. Berry, Benjamin L. Willis, Sachin Kumar Gupta, Carolyn E. Barlow, Susan C. Gilchrist, Amit Khera, Anand K. Rohatgi, James A. de Lemos, William L. Haskell, Donald M. Lloyd‐Jones · 2011 · Journal of the American College of Cardiology
57. XGBoost, A Novel Explainable AI Technique, in the Prediction of Myocardial Infarction: A UK Biobank Cohort Study
    Alexander Moore, Max Bell · 2022 · Clinical Medicine Insights Cardiology
58. Fibrates for primary prevention of cardiovascular disease events
    Jakob, Tobias, Nordmann, Alain J, Schandelmaier, Stefan, Ferreira-González, Ignacio, Briel, Matthias · 2016 · Cochrane Database of Systematic Reviews
59. Psychosocial risk factors in relation to other cardiovascular risk factors in coronary heart disease: Results from the EUROASPIRE IV survey. A registry from the European Society of Cardiology
    Погосова Нана Вачиковна, Kornelia Kotseva, Dirk De Bacquer, Roland von Känel, Delphine De Smedt, Jan Bruthans, Марина Миколаївна Долженко · 2017 · European Journal of Preventive Cardiology
60. Impact of cardiac rehabilitation and exercise training programs in coronary heart disease
    Sergey M. Kachur, Vasutakarn Chongthammakun, Carl J. Lavie, Alban De Schutter, Ross A Arena, Richard V. Milani, Barry A. Franklin · 2017 · Progress in Cardiovascular Diseases
61. Nutrients in Fish and Possible Associations with Cardiovascular Disease Risk Factors in Metabolic Syndrome
    Christine Tørris, Milada Cvancarova Småstuen, Marianne Molin · 2018 · Nutrients
62. Associations of Fish Consumption With Risk of Cardiovascular Disease and Mortality Among Individuals With or Without Vascular Disease From 58 Countries
    Deepa Mohan, Andrew Mente, Mahshid Dehghan, Sumathy Rangarajan, Martin James O'Donnell, Weihong Hu, Gilles R. Dagenais, Andreas T. Wielgosz, Scott Alexander Lear, Wei Li et al. · 2021 · JAMA Internal Medicine
63. The prevalence and impact of depression and anxiety in cardiac rehabilitation: a longitudinal cohort study
    Rao, A, Zecchin, R, Newton, PJ, Phillips, JL, DiGiacomo, M, Denniss, AR, Hickman, LD · 2020 · European Journal of Preventive Cardiology
64. Advances in lipid-lowering therapy through gene-silencing technologies
    Børge Grønne Nordestgaard, Stephen James Nicholls, Anne Langsted, Kausik Kumar Ray, Anne Tybjærg‐Hansen · 2018 · Nature Reviews Cardiology
65. Workplace bullying and workplace violence as risk factors for cardiovascular disease: a multi-cohort study
    Tianwei Xu, Linda L. Magnusson Hanson, Theis Lange, Liis Starkopf, Hugo Westerlund, Ida E H Madsen, Reiner Rugulies, Jaana Pentti, Sari Stenholm, Jussi Vahtera et al. · 2018 · European Heart Journal
66. Investigation and Treatment of High Blood Pressure in Young People
    Thomas Hinton, Zoe H. Adams, Richard P. Baker, Katrina A. Hope, Julian F. R. Paton, Emma C. Hart, Angus K. Nightingale · 2019 · Hypertension
67. The selective peroxisome proliferator-activated receptor alpha modulator (SPPARMα) paradigm: conceptual framework and therapeutic potential: A consensus statement from the International Atherosclerosis Society (IAS) and the Residual Risk Reduction Initiative (R3i) Foundation
    Fruchart, Jean-Charles, Santos, Raul D., Aguilar-Salinas, Carlos, Aikawa, Masanori, Al Rasadi, Khalid, Amarenco, Pierre, Barter, Philip J., Ceska, Richard, Corsini, Alberto, Després, Jean-Pierre et al. · 2019 · Cardiovascular Diabetology
68. Total cardiovascular risk approach to improve efficiency of cardiovascular prevention in resource constrain settings
    Shanthi Mendis, Lars Hjalmar Lindholm, Simon George Anderson, Ala Alwan, Rajendra Koju, Basden Onwubere, Azhar Mahmood Kayani, Nihal Abeysinghe, Alfredo Duneas, S Tabagari et al. · 2011 · Journal of Clinical Epidemiology
69. Effect of extended-release niacin on plasma lipoprotein(a) levels: A systematic review and meta-analysis of randomized placebo-controlled trials
    Amirhosssein Sahebkar, Željko Reiner, Luis E. Simental‐Mendía, Gianna Ferretti, Arrigo F.G. Cicero · 2016 · Metabolism
70. Cardiovascular disease in inflammatory rheumatic diseases
    Santos Castañeda, Michael Twahier Nurmohamed, Miguel Ángel González-Gay · 2016 · Best Practice & Research Clinical Rheumatology
71. Cardiovascular disease risk associated with elevated lipoprotein(a) attenuates at low low-density lipoprotein cholesterol levels in a primary prevention setting
    Rutger Verbeek, Renate M. Hoogeveen, Anne Langsted, Lotte C.A. Stiekema, Simone L. Verweij, G. Kees Hovingh, Nicholas J. Wareham, Kay‐Tee Khaw, S. Matthijs Boekholdt, Børge Grønne Nordestgaard et al. · 2018 · European Heart Journal
72. Impact of cocoa flavanol intake on age-dependent vascular stiffness in healthy men: a randomized, controlled, double-masked trial
    Christian Heiß, Roberto Sansone, Hakima Karimi, Moritz Krabbe, Dominik Schuler, Ana Rodriguez‐Mateos, Thomas Kræmer, Miriam Margherita Cortese-Krott, Gunter Kuhnle, Jeremy P.E. Spencer et al. · 2015 · AGE
73. Early onset hypercholesterolemia induced by the 2nd-generation tyrosine kinase inhibitor nilotinib in patients with chronic phase-chronic myeloid leukemia
    Delphine Réa, Tristan Mirault, Thomas Cluzeau, Jean–François Gautier, François Guilhot, Hervé Dombret, Emmanuel Messas · 2014 · Haematologica
74. Risk of venous thromboembolism in patients with psoriatic arthritis, psoriasis and rheumatoid arthritis: a general population-based cohort study
    Alexis Ogdie, Neilia‐Kay McGill, Daniel B. Shin, Junko Takeshita, Þorvarður Jón Löve, Megan H. Noe, Zelma C. Chiesa Fuxench, Hyon K. Choi, Nehal N. Mehta, Joel M. Gelfand · 2017 · European Heart Journal
75. Sex differences in risk factor management of coronary heart disease across three regions
    Min Zhao, Ilonca C. H. Vaartjes, Ian M Graham, Diederick E. Grobbee, Wilko Spiering, Kerstin Klipstein‐Grobusch, Mark Woodward, Sanne A. E. Peters · 2017 · Heart
76. Exercise training for patients with type 2 diabetes and cardiovascular disease: What to pursue and how to do it. A Position Paper of the European Association of Preventive Cardiology (EAPC)
    Hareld Kemps, Nicolle Kränkel, Marcus Dörr, Trine Tegdan Moholdt, Matthias Wilhelm, Francesco Paneni, Luis Serratosa, Erik Ekker Solberg, Dominique Hansen, Martin Halle et al. · 2019 · European Journal of Preventive Cardiology
77. Triglyceride glucose index is a useful marker for predicting subclinical coronary artery disease in the absence of traditional risk factors
    Gyung‐Min Park, Young–Rak Cho, Ki‐Bum Won, Yu Jin Yang, Sangwoo Park, Soe Hee Ann, Yong‐Giun Kim, Eun Ji Park, Shin‐Jae Kim, Sang-Gon Lee et al. · 2020 · Lipids in Health and Disease
78. Role of coronary artery calcium score in the primary prevention of cardiovascular disease
    Khurram Nasir, Miguel Cainzos‐Achirica · 2021 · BMJ
79. Cardiovascular effects of Glucagon-like peptide 1 (GLP-1) receptor agonists
    Saraiva, Francisco Kerr, Sposito, Andrei C · 2014 · Cardiovascular Diabetology
80. Accuracy of wearable heart rate monitors in cardiac rehabilitation
    Etiwy, Muhammad, Akhrass, Zade, Gillinov, Lauren, Alashi, Alaa, Wang, Robert, Blackburn, Gordon, Gillinov, Stephen M., Phelan, Dermot, Gillinov, A. Marc, Houghtaling, Penny L. et al. · 2019 · Cardiovascular Diagnosis and Therapy
81. Factors influencing participation in cardiac rehabilitation programmes after referral and initial attendance: qualitative systematic review and meta-synthesis
    Alexander Michael Clark, Kathryn M. King‐Shier, Melisa A. Spaling, Amanda S. Duncan, James A. Stone, Susan Brenda Jaglal, David R. Thompson, Jan Angus · 2013 · Clinical Rehabilitation
82. Mobile phone text messaging to improve medication adherence in secondary prevention of cardiovascular disease
    Alma J Adler, Nicole Martin, Javier A. Mariani, Carlos Daniel Tajer, Onikepe Oluwadamilola Owolabi, Caroline Free, Norma Cecilia Serrano, Juan Pablo Casas, Pablo Perel · 2017 · Cochrane Database of Systematic Reviews
83. Genetically Confirmed Familial Hypercholesterolemia in Patients With Acute Coronary Syndrome
    Almudena Amor‐Salamanca, Sergio Castillo, Emiliano González‐Vioque, Fernándo Domínguez, Lucía Quintana, Carla Lluís-Ganella, Juan Manuel Escudier-Villa, Javier Ortega, Enrique Lara‐Pezzi, Luis Alonso‐Pulpón et al. · 2017 · Journal of the American College of Cardiology
84. Incidence, risk factors and outcome of young patients with myocardial infarction
    Jarle Jortveit, Are Hugo Pripp, Jørund Langørgen, Sigrun Halvorsen · 2020 · Heart
85. Lifestyle changes for the treatment of nonalcoholic fatty liver disease: a review of observational studies and intervention trials
    Shira Zelber‐Sagi, Justyna Godos, Federico Salomone · 2016 · Therapeutic Advances in Gastroenterology
86. Clinical implication of an impaired fasting glucose and prehypertension related to new onset atrial fibrillation in a healthy Asian population without underlying disease: a nationwide cohort study in Korea
    Sean S. Lee, Kyoung Ae Kong, Daehoon Kim, Yeong-Min Lim, Pil‐Sung Yang, Jeong‐Eun Yi, Minsuk Kim, Kihwan Kwon, Wook Bum Pyun, Boyoung Joung et al. · 2017 · European Heart Journal
87. Prognostic value of coronary computed tomographic angiography findings in asymptomatic individuals: a 6-year follow-up from the prospective multicentre international CONFIRM study
    Iksung Cho, Subhi Jamal Alaref, Adam Berger, Bríain ó Hartaigh, Heidi Gransar, Valentina Valenti, Fay Yu-Huei Lin, Stephan S. Achenbach, Daniel S. Berman, Matthew Jay Budoff et al. · 2017 · European Heart Journal
88. Cardiovascular risk assessment: a global perspective
    Dong Hui Zhao, Jing Liu, Wuxiang Xie, Yue Qi · 2015 · Nature Reviews Cardiology
89. Psychosocial interventions for smoking cessation in patients with coronary heart disease
    Jürgen Barth, Tiffany Jacob, Ioana Cristina Daha, Julia Critchley · 2015 · Cochrane Database of Systematic Reviews
90. Patients with coronary artery disease and diabetes need improved management: a report from the EUROASPIRE IV survey: a registry from the EuroObservational Research Programme of the European Society of Cardiology
    On behalf of the EUROASPIRE Investigators, Gyberg, Viveca, De Bacquer, Dirk, De Backer, Guy, Jennings, Catriona, Kotseva, Kornelia, Mellbin, Linda, Schnell, Oliver, Tuomilehto, Jaakko, Wood, David et al. · 2015 · Cardiovascular Diabetology
91. Phytosterols, Phytostanols, and Lipoprotein Metabolism
    Helena Gylling, Piia P. Simonen · 2015 · Nutrients
92. Effect of High-Dose Trivalent vs Standard-Dose Quadrivalent Influenza Vaccine on Mortality or Cardiopulmonary Hospitalization in Patients With High-risk Cardiovascular Disease
    Orly Vardeny, KyungMann Kim, Jacob Allen Udell, Jacob Joseph, Akshay Suvas Desai, Michael E. Farkouh, Sheila M. Hegde, Adrian F. Hernandez, Allison McGeer, H. Keipp Talbot et al. · 2020 · JAMA
93. Individualized Guidelines: The Potential for Increasing Quality and Reducing Costs
    David M. Eddy, Joshua S. Adler, Bradley Patterson, Don Lucas, Kurt A. Smith, Macdonald Morris · 2011 · Annals of Internal Medicine
94. Effectiveness of pharmacist’s intervention in the management of cardiovascular diseases
    Stefano Omboni, Marina Caserini · 2018 · Open Heart
95. Asleep blood pressure: significant prognostic marker of vascular risk and therapeutic target for prevention
    Ramón C. Hermida, Juan J. Crespo, Alfonso Otero, Manuel Domínguez-Sardiña, Ana Moyá, María Teresa Paulín Ríos, Maria C. Castiñeira, Pedro A. Callejas, Lorenzo Pousa, Elvira Sineiro et al. · 2018 · European Heart Journal
96. Primary care in the time of COVID-19: monitoring the effect of the pandemic and the lockdown measures on 34 quality of care indicators calculated for 288 primary care practices covering about 6 million people in Catalonia
    Ermengol Coma, Núria Mora, Leonardo Méndez-Boo, Mència Benítez, Eduardo Hermosilla, Mireia Fàbregas, Francesc Fina Avilés, Albert Mercadé, Souhel Flayeh Beneyto, Carolina Guiriguet et al. · 2020 · BMC Family Practice
97. Importance of characteristics and modalities of physical activity and exercise in defining the benefits to cardiovascular health within the general population: recommendations from the EACPR (Part I)
    Luc Vanhees, Johan DE SUTTER, Nickos D. Geladas, Frank Doyle, Eva Prescott, Véronique Cornelissen, Evangelia Joseph Kouidi, Dorian Dugmore, Diego Vanuzzo, Mats Börjesson et al. · 2012 · European Journal of Preventive Cardiology
98. Whole grain consumption and human health: an umbrella review of observational studies
    Maria Tieri, Francesca Ghelfi, Marilena Vitale, Claudia Vetrani, Stefano Marventano, Alessandra Lafranconi, Justyna Godos, Lucilla Titta, Angelo Gambera, Elena Alonzo et al. · 2020 · International Journal of Food Sciences and Nutrition
99. HDL-C is associated with mortality from all causes, cardiovascular disease and cancer in a J-shaped dose-response fashion: a pooled analysis of 37 prospective cohort studies
    Guo‐Chao Zhong, Su-Qun Huang, Yang Peng, Lun Wan, You‐Qi‐Le Wu, Tianyang Hu, Jie‐Jun Hu, Fa‐Bao Hao · 2020 · European Journal of Preventive Cardiology
100. The Stroke Riskometer™ App: Validation of a Data Collection Tool and Stroke Risk Predictor
     Priya G Kumari Parmar, Rita Krishnamurthi, M. Arfan Ikram, Albert Hofman D, Saira Saeed Mirza, Yu. Ya. Varakin, Michael A Kravchenko, М. А. Пирадов, Amanda Gay Thrift, Bo G Norrving et al. · 2014 · International Journal of Stroke